Business NewsRadical ConsumeristSilicon Valley InsiderWealthy Biotech Trader

Top 5 Short Squeeze Candidates Investors Should Keep An Eye On

As the Likelihood of a Recession Continues to Increase and Stock Prices Continue to Fall, the Amount of Short Interest in Stocks Throughout the Market Continues to Rise

With High Short Interest Also Comes the Potential For a Short Squeeze, and We’ve Identified Five Stocks That Could Be Prime For a Big Squeeze

While being short at this time is likely a good play, certain stocks seem to be traps for shorts, with the chance of a short squeeze elevated relative to other companies.

Per Investopedia:

“A short squeeze is an unusual condition that triggers rapidly rising prices in a stock or other tradable security. For a short squeeze to occur, the security must have an unusual degree of short-sellers holding positions in it. The short squeeze begins when the price jumps higher unexpectedly. The condition plays out as a significant measure of the short sellers coincidentally decide to cut losses and exit their positions.”

Here are five stock investors should keep an eye on for an opportunity to get in before a potential short squeeze starts.

1. Eliem Therapeutics (NASDAQ: ELYM)

Primarily focused on nervous system disorders, Eliem Therapeutics has four different programs currently going through clinical trials but does not yet have a product on the market. Like most upstart biotechnology companies, Eliem is banking on its positive results thus far, drawing interest from major pharmaceutical companies. The investing community has a dim view of the stock, with 36% of the float being short and the cost of borrowing on shares being 16.5%.

Eliem Therapeutics closed today’s trading session at $3.11 per share, down -14.56% on the day. YTD, ELYM stock is down -71.44%.

Learn more about Eliem Therapeutics: Website | Investor Deck | ELYM Chart

2. Revlon (NYSE: REV)

After declaring bankruptcy last week, Revlon has been rallying strongly. Investors seem to think the filing was a positive step for the company moving forward. However, not everyone is convinced that this rally is sustainable; more than 37% of shares are short, despite the eye-watering cost of borrowing of 172%. Until bankruptcy proceedings are finished, we won’t know if the longs or the shorts are on the right track.

Revlon closed Wednesday at $4.59 per share, down -17% on the day. YTD, REV stock is down -60.63%.

Learn more about Revlon: Website | Investor Deck | REV Chart

Source: Shutterstock

????Also Read: Why the Stock Market Likely Hasn’t Bottomed and You Shouldn’t “Buy the Dip” Yet

3. TherapeuticsMD (NASDAQ: TXMD)

Specifically targeting health issues experienced by women, TherapeuticsMD was founded over a century ago. The majority of their revenues come from three products: ANNOVERA (contraceptive), IMVEXXY (estrogen supplement) and BIJUVA (estrogen and progesterone supplement).  24% of shares are short, and the cost to borrow has fallen from 75% to 28% over the last week.

TherapeuticsMD closed trading today at $9.93 per share, up +0.1% on the day. YTD, TXMD stock is down -49.54%.

Learn more about TherapeuticsMD: Website | Investor Deck | TXMD Chart

4. Tuscan Holdings (NASDAQ: THCA)

A leftover from last year’s hay day, Tuscan Holdings is one of dozens of SPACs that has yet to make their qualified transaction. When the blank check company stood up, management was targeting cannabis companies. After the bottom fell out of the cannabis market, the company shifted its focus and settled on acquiring Surf Air Mobility, a subscription-based private plane service. The company has submitted a fifth (!) request to extend its acquisition deadline due to its inability to close a deal. Investors aren’t optimistic about Tuscan’s future, with 55% of shares short and a cost to borrow of 9%.

Tuscan Holdings last traded at $10.34 per share, even on the day. YTD, THCA stock is up +1.37%.

Learn more about Tuscan Holdings: Website | Investor Deck | THCA Chart

5. Weber (NYSE: WEBR)

The most recognized name in home grills was founded in 1893 but didn’t go public until 2021. Weber estimates that there are currently 50 million of their grills installed across the 76 countries they operate in. Unfortunately, the stock has lost over half its value since its IPO, and shorts believe it is going even lower. A whopping 56% of shares are short, the highest on our list, and the cost to borrow sits at 50%.

Weber closed trading on Wednesday at $7.62 per share, down -6.62% on the day. YTD, WEBR stock is down -38.25%.

Learn more about Weber: Website | Investor Deck | WEBR Chart

* Attention readers on mobile or tablet, if you cannot view the above chart in its entirety, please rotate yo r device sid ways. Make sure you have your portrait orientation lock switched off.

Did you enjoy this article? If so, consider signing up for the Wealthy VC Email Newsletter below to start receiving our weekly newsletter featuring the week’s best articles.

Follow Wealthy VC on Social Media: Facebook | Instagram | Twitter | LinkedIn | GETTR

????Join the Discussion in the Wealthy VC Investor Group

????Have a Stock Tip or New  Story Suggestion? Email us at Invest@WealthyVC.com

Disclaimer: Wealthy VC does not hold a position in any of the stocks mentioned in this article.

Shawn V.

Shawn is Marine veteran, originally from the San Francisco Bay Area. Shawn has a BS in Hospitality Management and an MBA, from the University of Nevada. In addition to writing for Wealthy VC, Shawn is also a writer for the financial website Seeking Alpha. Seeking Alpha | Email

Related Articles

Back to top button